THYMIDINE KINASE 2 DEFICIENCY
Clinical trials for THYMIDINE KINASE 2 DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new THYMIDINE KINASE 2 DEFICIENCY trials appear
Sign up with your email to follow new studies for THYMIDINE KINASE 2 DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for rare muscle disease
Disease control OngoingThis phase 2 study tests a combination of two nucleoside drugs, doxecitine and doxribtimine, in 47 people with thymidine kinase 2 (TK2) deficiency, a rare genetic disorder that weakens muscles. Participants already receiving nucleoside therapy continue treatment to see if the dru…
Matched conditions: THYMIDINE KINASE 2 DEFICIENCY
Phase: PHASE2 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Experimental treatment aims to boost mitochondrial DNA in rare disease
Disease control OngoingThis study tests two natural substances, deoxythymidine and deoxycytidine, in people with TK2 deficiency, a rare genetic condition that causes muscle weakness and breathing problems. The goal is to see if these nucleotide precursors can help cells make more mitochondrial DNA and …
Matched conditions: THYMIDINE KINASE 2 DEFICIENCY
Phase: PHASE1, PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC